<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Kapadia, Samir R.</style></author><author><style face="normal" font="default" size="100%">Feldman, Ted</style></author><author><style face="normal" font="default" size="100%">Kar, Saibal</style></author><author><style face="normal" font="default" size="100%">Cleman, Michael W.</style></author><author><style face="normal" font="default" size="100%">Buchbinder, Maurice</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Updates in Mitral Valve Repair and Replacement</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-06-25 12:08:30</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">15-18</style></pages><abstract><style  face="normal" font="default" size="100%">Mitral regurgitation, depending on severity and symptoms, may require treatment. Current options include the repair and replacement of the mitral valve. There is a trend of favoring transcatheter approaches, particularly in high-risk patients with comorbidities. In addition, emerging mitral valve prosthetics are in development and may provide additional options for these patients.</style></abstract><number><style face="normal" font="default" size="100%">10</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>